Dried blood spot IP-10 as a biomarker of tuberculosis severity and treatment responses: results from a phase IIb trial of adjunctive acetylsalicylic acid and ibuprofen.
Høgbakk Edlund I, Alonso-Rodriguez N, Sopegno C, Farrés J, Gogichadze N, Arias L, Fonseca KL, Otwombe K, Waja Z, Moloantoa T, Pillay N, Seiphetlo T, Martinson N, Vilaplana C, Dyrhol-Riise AM
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.